Correlation Between Nuvectis Pharma and Ventyx Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nuvectis Pharma and Ventyx Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvectis Pharma and Ventyx Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvectis Pharma and Ventyx Biosciences, you can compare the effects of market volatilities on Nuvectis Pharma and Ventyx Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvectis Pharma with a short position of Ventyx Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvectis Pharma and Ventyx Biosciences.

Diversification Opportunities for Nuvectis Pharma and Ventyx Biosciences

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between Nuvectis and Ventyx is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and Ventyx Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ventyx Biosciences and Nuvectis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvectis Pharma are associated (or correlated) with Ventyx Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ventyx Biosciences has no effect on the direction of Nuvectis Pharma i.e., Nuvectis Pharma and Ventyx Biosciences go up and down completely randomly.

Pair Corralation between Nuvectis Pharma and Ventyx Biosciences

Given the investment horizon of 90 days Nuvectis Pharma is expected to under-perform the Ventyx Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Nuvectis Pharma is 1.27 times less risky than Ventyx Biosciences. The stock trades about 0.0 of its potential returns per unit of risk. The Ventyx Biosciences is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  220.00  in Ventyx Biosciences on September 7, 2024 and sell it today you would earn a total of  31.00  from holding Ventyx Biosciences or generate 14.09% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Nuvectis Pharma  vs.  Ventyx Biosciences

 Performance 
       Timeline  
Nuvectis Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nuvectis Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Ventyx Biosciences 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Ventyx Biosciences are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Ventyx Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.

Nuvectis Pharma and Ventyx Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nuvectis Pharma and Ventyx Biosciences

The main advantage of trading using opposite Nuvectis Pharma and Ventyx Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvectis Pharma position performs unexpectedly, Ventyx Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ventyx Biosciences will offset losses from the drop in Ventyx Biosciences' long position.
The idea behind Nuvectis Pharma and Ventyx Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios